CVS Health Corporation $CVS Shares Bought by Wedmont Private Capital

Wedmont Private Capital grew its position in CVS Health Corporation (NYSE:CVS) by 47.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 30,342 shares of the pharmacy operator’s stock after acquiring an additional 9,707 shares during the period. Wedmont Private Capital’s holdings in CVS Health were worth $2,600,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Handelsbanken Fonder AB grew its holdings in CVS Health by 83.6% during the 2nd quarter. Handelsbanken Fonder AB now owns 1,089,694 shares of the pharmacy operator’s stock worth $112,729,000 after acquiring an additional 496,124 shares during the last quarter. BNP Paribas increased its position in CVS Health by 105.2% in the 2nd quarter. BNP Paribas now owns 49,971 shares of the pharmacy operator’s stock valued at $5,154,000 after acquiring an additional 25,617 shares in the last quarter. Nykredit A S bought a new position in shares of CVS Health in the second quarter worth about $209,813,000. State Street Corp raised its stake in shares of CVS Health by 2.1% in the fourth quarter. State Street Corp now owns 60,183,743 shares of the pharmacy operator’s stock worth $4,776,182,000 after acquiring an additional 1,245,457 shares during the last quarter. Finally, Oppenheimer Asset Management Inc. acquired a new position in shares of CVS Health during the second quarter worth approximately $49,622,000. 80.66% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. Wells Fargo & Company raised their price target on shares of CVS Health from $103.00 to $123.00 and gave the company an “overweight” rating in a report on Monday, July 13th. Wall Street Zen downgraded CVS Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, October 3rd. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 5th. BMO Capital Markets set a $112.00 price target on CVS Health in a research note on Wednesday, September 9th. Finally, Barclays raised their price target on CVS Health from $106.00 to $108.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Twenty-one investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $107.24.

CVS Health Stock Performance

Shares of CVS Health stock opened at $86.15 on Friday. The firm has a fifty day moving average of $92.73 and a two-hundred day moving average of $92.37. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87. The stock has a market capitalization of $110.18 billion, a price-to-earnings ratio of 22.79, a PEG ratio of 0.82 and a beta of 0.60. CVS Health Corporation has a 52 week low of $69.51 and a 52 week high of $110.68.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%. The firm’s revenue was up 7.3% on a year-over-year basis. During the same period last year, the company earned $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, equities research analysts predict that CVS Health Corporation will post 8.02 EPS for the current year.

CVS Health Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, November 2nd. Shareholders of record on Thursday, October 22nd will be issued a $0.6650 dividend. The ex-dividend date is Thursday, October 22nd. This represents a $2.66 annualized dividend and a yield of 3.1%. CVS Health’s dividend payout ratio (DPR) is 70.37%.

Key Stories Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: CVS said more than 69% of Aetna’s Medicare Advantage members are enrolled in plans rated four stars or higher for 2027. The company highlighted solid clinical quality, preventive care and member-experience performance. Aetna 2027 Star Ratings Reflect Strong Clinical Quality and Member Experience
• Positive Sentiment: CVS extended pharmaceutical distribution agreements with Cardinal Health and McKesson through 2032, supporting supply continuity for its retail pharmacies and other dispensing operations. CVS Health Extends Drug Distribution Deals
• Positive Sentiment: Analysts continue to point to potential upside from recovering Aetna margins, improving pharmacy trends, growth in Health Services and CVS’s valuation discount versus peers. The company also opened a compact, pharmacy-focused location in the Boston area, supporting its retail strategy. CVS Trades at a Discount to Industry
• Neutral Sentiment: Options traders reportedly purchased a large volume of CVS call options, signaling speculative bullish interest but not guaranteeing sustained buying in the shares. Traders Buy CVS Call Options
• Negative Sentiment: TD Cowen said Aetna’s 2027 results were weaker than expected, with the portion of Medicare Advantage members in plans rated at least 4.5 stars projected to fall to about 35% from 63%. The decline could reduce quality-related bonus payments and put pressure on Aetna’s earnings and margins. CVS Star Ratings Weaker Than Expected
• Negative Sentiment: The ratings setback has made CVS an underperformer among managed-care stocks, while competitors with stronger Medicare Advantage scores received more favorable investor reactions. Persistent 340B pricing pressure remains an additional risk to the recovery story.

About CVS Health

CVS Health Corp. is an integrated health care company that provides pharmacy, insurance and health services primarily in the United States. Its operations are designed to connect consumers, health plans, health care providers and pharmacy services across multiple points of care.

The company’s major businesses include CVS Pharmacy retail locations, prescription fulfillment and consumer health products; CVS Caremark, a pharmacy benefit management business; and Aetna, which offers health insurance products and related services for employers, individuals, government programs and other organizations.